The beneficial effects of natural Treg cells, which express CD4+ forkhead box protein 3 (FoxP3), and T regulatory type 1 (Tr1) cells, which produce IL-10, on autoimmune neuroinflammation have been demonstrated in both MS patients (62, 63) and experimental animal models (64, 65). This evidence concerns the gene IL10 and myeloid sarcoma.